Medication info

Surametin Tablet (Cimetidine)

Prescription medicationTabletExpired
Ingredient · strength
Cimetidine›200mg / 1 tablet
Manufacturer / importer
Bionex Co., Ltd.
Appearance
Light green film-coated tablets
Packaging
600 tablets/bottle
Approval status
Expired

MFDS item code 197900149 · Notified 1979.04.28

This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of gastric acid-related conditions (such as ulcers and reflux esophagitis) and gastritis-related gastric mucosal lesions
Who uses it
Adults · Children
Adult dosage
Adults: Administer 400 mg of cimetidine twice daily (in the morning and at bedtime) orally, or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally 4 times daily (after meals and at bedtime). The dose may be increased to 400 mg 4 times daily (after meals and at bedtime) (total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, erythema, and edema) associated with acute gastritis or acute exacerbation of chronic gastritis, administer 200 mg twice daily or 400 mg once daily. Antacids may be administered as needed for pain relief. The dose may be increased in some patients; in such cases, increase the frequency of administration rather than the dose per administration. Do not exceed 2.4 g per day. Patients with renal impairment: Administer 300 mg of this medicine twice daily, at 12-hour intervals. If necessary, depending on the patient's symptoms, the frequency may be increased to 3 times daily, every 8 hours, or more, but use caution. In patients with severe renal impairment, the medicine may accumulate in the body; therefore, reduce the frequency of administration to the minimum based on the patient's response. Hemodialysis lowers the blood cimetidine concentration. After hemodialysis is completed, administer the medicine again according to the schedule. Adjust the dose appropriately according to age and symptoms.
Children's dosage
Children: Administer 20 〜 40 mg/kg of body weight per day orally in divided doses.

Ingredients

Manufacturer
Bionex Co., Ltd.

Efficacy & effects

Improvement of gastric acid-related conditions (such as ulcers and reflux esophagitis) and gastritis-related gastric mucosal lesions

  • Gastric ulcer
  • duodenal ulcer
  • gastroesophageal reflux disease
  • recurrent ulcer
  • anastomotic ulcer
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
  • swelling
  • acute gastritis
View approved original text

This medication is used for various gastrointestinal disorders such as gastric and duodenal ulcers, gastroesophageal reflux disease, recurrent ulcers, anastomotic ulcers, and Zollinger-Ellison syndrome. It also helps to alleviate symptoms such as erosion, bleeding, redness, and swelling of the gastric mucosa that occur during acute exacerbations of acute and chronic gastritis. Due to these effects, it is effective in restoring the patient's gastric health and relieving uncomfortable symptoms.

Dosage and Administration

Adult dosage

Adults: Administer 400 mg of cimetidine twice daily (in the morning and at bedtime) orally, or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally 4 times daily (after meals and at bedtime). The dose may be increased to 400 mg 4 times daily (after meals and at bedtime) (total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, erythema, and edema) associated with acute gastritis or acute exacerbation of chronic gastritis, administer 200 mg twice daily or 400 mg once daily. Antacids may be administered as needed for pain relief. The dose may be increased in some patients; in such cases, increase the frequency of administration rather than the dose per administration. Do not exceed 2.4 g per day. Patients with renal impairment: Administer 300 mg of this medicine twice daily, at 12-hour intervals. If necessary, depending on the patient's symptoms, the frequency may be increased to 3 times daily, every 8 hours, or more, but use caution. In patients with severe renal impairment, the medicine may accumulate in the body; therefore, reduce the frequency of administration to the minimum based on the patient's response. Hemodialysis lowers the blood cimetidine concentration. After hemodialysis is completed, administer the medicine again according to the schedule. Adjust the dose appropriately according to age and symptoms.

Children's dosage

Children: Administer 20 〜 40 mg/kg of body weight per day orally in divided doses.

Precautions

This medication should be handled with great care when cutting the container of glass ampules to avoid contamination with glass fragments, which can cause adverse reactions. Extra caution is required when used in children or the elderly. It should not be administered to patients with hypersensitivity to this medication or who have previously shown allergic reactions to this medication or its components. In addition, patients taking dofetilide should not use this medication together due to increased risk of heart arrhythmias. This medication contains lactose and should not be administered to patients with lactose intolerance or specific metabolic disorders. Patients with impaired renal or liver function may have increased blood concentration of this medication; therefore, they should use it cautiously by reducing the dose or extending the intervals between doses. Elderly patients, children under 19 years, and patients undergoing hemodialysis should also be cautious, and especially since symptoms of gastric cancer can be masked, it should only be used after confirming malignancy. This medication includes Yellow No. 4 (tartrazine) dye, and should be used with caution in patients allergic to this component. While taking this medication, rare side effects such as decreased blood cell count, liver dysfunction, renal function impairment, hypersensitivity reactions, endocrine symptoms, gastrointestinal symptoms, neurological symptoms, and skin reactions may occur. If these symptoms appear, discontinue use immediately and consult a physician. If therapeutic effects are not observed or adverse reactions are suspected, alternative treatments may be considered; patients with a history of peptic ulcers, elderly patients, or those with chronic diseases should undergo regular monitoring. This medication can interact with various drugs; therefore, patients taking other medications must inform their healthcare provider, particularly when combined with anticoagulants, anticonvulsants, cardiac medications, or antibiotics. Women who are pregnant or may become pregnant should carefully consider the benefits and risks of using this medication. Nursing mothers are advised to discontinue breastfeeding while using this medication. Safety in children has not been sufficiently established; it should only be used in necessary cases, and elderly patients may require dose adjustments considering renal function declines. In cases of overdose, severe symptoms such as respiratory depression may occur, necessitating immediate medical attention for appropriate treatment. When used as an injection, rapid intravenous administration may lead to arrhythmias or decreased blood pressure, so it should be infused slowly. This medication should be stored out of reach of children and it is important to avoid transferring the medication to another container to maintain its quality.

Side effects

  • Leukopenia
  • granulocytopenia
  • agranulocytosis
  • thrombocytopenia
  • pancytopenia
  • aplastic anemia
  • autoimmune hemolytic anemia
  • jaundice
  • hepatitis
  • elevated AST
Show 47 more
  • elevated ALT
  • liver fibrosis
  • epileptic seizures
  • acute renal failure
  • interstitial nephritis
  • urinary retention
  • elevated BUN
  • shock
  • anaphylactic reaction
  • hypersensitivity vasculitis
  • rash
  • gynecomastia
  • galactorrhea
  • increased leukorrhea
  • erectile dysfunction
  • abdominal distension
  • constipation
  • diarrhea
  • headache
  • dizziness
  • seizures
  • limb numbness
  • rigidity
  • drowsiness
  • hypochondriac symptoms
  • weakness
  • altered consciousness
  • confusion
  • bradycardia
  • tachycardia
  • palpitations
  • atrioventricular block
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • epidermal necrosis
  • erythema multiforme
  • exfoliative dermatitis
  • generalized exfoliative erythema
  • fatigue
  • fever
  • systemic heat sensation
  • dysuria
  • myalgia
  • arthralgia
  • pancreatitis
  • hair loss
  • polymyositis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from entering, ideally at room temperature between 1 and 30 degrees Celsius. Proper storage can maintain the efficacy of the medication over time.

Appearance and packaging

Appearance

Light green film-coated tablets

Package unit

600 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.